Columbia, SC, United States of America

Michael J Dewey

This inventor holds 1 USPTO granted patent. Top assignees: Health Research, Inc., University of South Carolina. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Dewey. Retrieved from https://idiyas.com/inventor/michael-j-dewey-z4tkfp8p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael J Dewey: Innovator in Transgenic Research

Introduction

Michael J Dewey is a notable inventor based in Columbia, SC (US). He has made significant contributions to the field of transgenic research, particularly through his innovative work involving alpha-1-acid glycoprotein.

Latest Patents

Dewey holds a patent for "Alpha-1-acid glycoprotein transgenic mice." This invention involves mice that heritably carry alpha-1-acid glycoprotein (AGP) genes, which can be introduced using transgenic methodology. These animal models serve various purposes, including the assessment of the in vivo role of AGP in drug clearance, the influence of AGP on the pharmacological activity of drugs, testing hypotheses concerning AGP function, and identifying AGP gene cis-acting regulatory features. He has 1 patent to his name.

Career Highlights

Throughout his career, Dewey has worked with esteemed institutions such as the University of South Carolina and Health Research, Inc. His research has contributed to advancements in understanding drug interactions and pharmacology.

Collaborations

Dewey has collaborated with notable professionals in his field, including Heinz Baumann. Their joint efforts have furthered research in transgenic methodologies and applications.

Conclusion

Michael J Dewey's innovative work in transgenic research has paved the way for significant advancements in pharmacological studies. His contributions continue to impact the scientific community and enhance our understanding of drug interactions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…